[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594105":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":12,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":12,"enrollmentInfo":59,"targetDuration":12,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":69,"overallStatus":32,"whyStopped":12,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Parc Sanitari Pere Virgili","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control (usual care)","NO_INTERVENTION","Control arm will receive usual standard of care",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention (patient-centered medication review)","EXPERIMENTAL","Intervention arm will receive a multidisciplinary patient-centered medication review",[18],"Other: Patient-centered multidisciplinary treatment review",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"Patient-centered multidisciplinary treatment review","Patient-centered multidisciplinary treatment review is defined as a medication review conducted by a multidisciplinary team (geriatrician, clinical pharmacist, nurse) according to a patient-centered methodology, based on person-centered evaluation of both personal and clinical insights, diagnostic-centered evaluation (based on current guidelines), and drug-centered evaluation (based on adequacy)",[14],[25],{"name":26,"role":27,"phone":28,"phoneExt":12,"email":29},"Ana M de Andrés Lázaro, Pharmacist. PhD","CONTACT","+34932594128","amandres@perevirgili.cat",[31],{"facility":5,"status":32,"city":33,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Barcelona","08023","Spain","ES",{"type":38,"coordinates":39},"Point",[40,41],2.15899,41.38879,{"lat":41,"lon":40},[44],{"name":45,"role":27,"phone":46,"phoneExt":12,"email":29},"Ana M de Andrés Lázaro, Pharmacist, PhD","+34 93 259 41 28",{"type":48,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100594105","applying-a-multidisciplinary-intervention-for-drug-adequacy-in-an-intermediate-care-hospital-amida-ich-100594105",false,"NCT07015112","Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH)","Applying a Multidisciplinary Intervention for Drug Adequacy in a Intermediate Care Hospital (AMIDA-ICH)","AMIDA-ICH","Inclusion Criteria:\n\n* older adults (65+ years)\n* ≥ 3 or more chronic conditions requiring medical therapy\n* able to speak Spanish\n* capacity to provide informed consent or have a surrogate able to consent on their behalf\n\nExclusion Criteria:\n\n* unable to provide informed consent\n* anticipated length of hospital stay \\\u003C 72h\n* estimated life expectancy \\\u003C 3 months\n* homeless\n* already enrolled in a drug trial","ALL","65 Years",{"count":60,"type":61},300,"ESTIMATED","INTERVENTIONAL",[64],"NA","The goal of this clinical trial is to learn if a multi-professional (conducted by geriatricians, clinical pharmacists, nurses) medication revision, centered on patients' goals and characteristics, can improve treatment adequacy in older adults admitted to an intermediate care hospital.\n\nThe main question it aims to answer is: does this approach reduce the average number of medications taken per patient?\n\nResearchers will compare this multi-professional patient-centered revision to the usual standard of care (treatment revision conducted by a clinical pharmacist) to see if the patient-centered revision works in improving treatment adequacy.\n\nParticipants admitted to an intermediate care hospital will undergo a comprehensive assessment by a geriatrician, and a medication revision (conducted by a multidisciplinary team or a clinical-pharmacist alone). They will also be asked to fulfill some questionnaires on their health status and attitudes. Any possible adverse events to the medications will be recorded at discharge. Participants will be contacted again three months after discharge to check for any readmission or death.",[67,68],"Poly Pharmacy","Frail Elderly",[70,71,72,73],"polypharmacy","frailty","adverse drug event","deprescribing","2025-06-10",{"date":76,"type":77},"2025-06-11","ACTUAL",{"date":79,"type":77},"2024-01-04",{"date":81,"type":61},"2026-06",{"name":5,"class":6},1]